Pulmokine Receives $1 Million Investment from Broadview Ventures to Advance PAH Candidate into First Clinical Trial Rensselaer, NY, March 3, 2015 (GLOBE NEWSWIRE) -- Pulmokine announced today that it has entered into an investment agreement with Broadview Ventures for $1 Million. Proceeds will be used to...